Cellectar Biosciences, Inc. (CLRB)

Import this data to Google Sheets with:

=jivedata("CLRB","financials")

Full statements spill as a table. For one cell: =jivedata("CLRB","Revenue") or =jivedata("CLRB","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Cellectar Biosciences, Inc.

CLRB • CIK 0001279704

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Research and Development Expense	$28,211.46	$26,136.246	$11,498.761	$13,246.477
General and Administrative Expense	$10,749.183	$25,641.452	$11,481.083	$10,284.8
Operating Income (Loss)	$-38,960.643	$-51,777.698	$-22,979.844	$-23,531.277
Costs and Expenses	$38,960.643	$51,777.698	$22,979.844	$23,531.277
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-38,043.496	$-44,515.446	$-21,791.037	$-21,791.037
Income Tax Expense (Benefit)	$-60	$66	$66	$66
Net Income (Loss) Attributable to Parent	$-37,983.496	$-44,581.446	$-21,791.037	$-22,323.695
Weighted Average Number of Shares Outstanding, Basic	12,221,571	36,622,474	2,608,317	9,293,786
Weighted Average Number of Shares Outstanding, Diluted	12,221,571	37,143,769	2,608,317	9,293,786
Fair Value Adjustment of Warrants	$-1,000	$-13,794.683	$-753.707	$-801.109
Interest Income (Expense), Nonoperating, Net	$387.147	$1,210.853	$435.1	$406.473
Nonoperating Income (Expense)	$917.147	$7,262.252	$1,188.807	$1,207.582

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Property, Plant and Equipment, Net	$1,090.304	$757.121	$549.405	$304.173
Operating Lease, Right-of-Use Asset	$502.283	$436.874	$360.671	$1,433.706
Other Assets, Noncurrent	$6.214	$29.78	$29.78	$23.566
Assets	$12,075.58	$25,474.047	$14,978.321	$36,639.086
Operating Lease, Liability, Noncurrent	$494.003	$409.586	$309.397	$1,529.542
Liabilities	$13,431.627	$9,797.343	$5,059.134	$6,767.253
Cash and Cash Equivalents, at Carrying Value	$9,564.988	$23,288.607	$13,196.033	$33,993.982
Prepaid Expense and Other Assets, Current	$888.225	$961.665	$842.432	$883.659
Assets, Current	$10,453.213	$24,250.272	$14,038.465	$34,877.641
Accounts Payable and Accrued Liabilities, Current	$9,178.645	$7,585.34	$4,423.548	$5,218.681
Derivative Liability, Current	$3,700	$1,718	$226	$17
Operating Lease, Liability, Current	$58.979	$84.417	$100.189	$2.03
Liabilities, Current	$12,937.624	$9,387.757	$4,749.737	$5,237.711
Common Stock, Value, Issued	$0.207	$0.461	$0.042	$0.083
Additional Paid in Capital	$210,066.63	$261,115.905	$277,149.844	$311,589.849
Retained Earnings (Accumulated Deficit)	$-217,482.539	$-247,342.463	$-269,133.5	$-281,718.099
Stockholders' Equity Attributable to Parent	$-1,356.047	$14,294.681	$8,537.164	$29,871.833
Common Stock, Shares Authorized	170,000,000	170,000,000	170,000,000	170,000,000
Common Stock, Shares, Issued	20,744,110	46,079,875	4,240,129	8,252,108

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-37,983.496	$-44,581.446	$-21,791.037	$-22,323.695
Net Cash Provided by (Used in) Operating Activities	$-32,376.974	$-47,583.001	$-23,118.217	$-19,474.999
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-10,301.37	$13,723.619	$-10,092.574	$22,952.955
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$9,564.988	$23,288.607	$13,196.033	$7,637.95
Depreciation, Depletion and Amortization	$192.375	$291.653	$213.597	$213.597
Payments to Acquire Property, Plant, and Equipment	$864.038	$104.195	$5.88	$5.88
Share-based Payment Arrangement, Noncash Expense	$2,410.288	$4,272.78	$2,263.704	$2,015.751
Net Cash Provided by (Used in) Investing Activities	$-864.038	$-104.195	$-5.88	$-5.88
Gain (Loss) on Disposition of Assets	$-3.386	$-145.726	$-145.726	$-145.726
Fair Value Adjustment of Warrants	$-1,000	$-13,794.683	$-753.707	$-801.109
Operating Lease, Right-of-Use Asset, Amortization Expense	—	$65.409	$76.202	$76.202
Proceeds from Warrant Exercises	$789.642	$61,410.815	$7,243.143	$7,243.143
Net Cash Provided by (Used in) Financing Activities	$22,939.642	$61,410.815	$13,031.523	$42,437.212
Conversion of Stock, Amount Converted	—	$67,648.487	$67,648.487	—
Increase (Decrease) in Prepaid Expense and Other Assets	$173.548	$73.44	$-119.233	$-1,022.238
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$3,700.202	$-1,593.305	$-3,161.792	$539.968
IncreaseDecreaseInOperatingLeaseLiability	$-50.846	$-58.979	$-84.417	$-41.176

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("CLRB","financials")

Full statements spill as a table. For one cell: =jivedata("CLRB","Revenue") or =jivedata("CLRB","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.